References
- Hedner, U. and Ingerslev, J. (1998) “Clinical use of recombinant factor VIIa (rFVIIa)”, Transfus. Sci. 19, 163–176.
- Key, N.S., Aledort, L.M., Beardsley, D., et al., (1998) “Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors”, Thromb. Haemost. 80, 912–918.
- Shapiro, A.D., Gilchrist, G.S., Hoots, W.K., Cooper, H.A. and Gastineau, D.A. (1998) “Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery”, Thromb. Haemost. 80, 773–778.
- Hedner, U. (1998) “Recombinant activated factor VII as a universal haemostatic agent”, Blood Coag. Fibrin. 9(suppl. 1), S147–S152.
- Bernstein, D.E., Jeffers, L., Erhardtsen, E., et al., (1997) “Recombinant factor VIIa corrects the prothrombin time in cirrhotic patients: a preliminary study”, Gastroenterology 113, 1930–1937.
- Erhardtsen, E., Nony, P., Dechavanne, M., Ffrench, P., Boissel, J.P. and Hedner, U. (1998) “The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an international normalized ratio above 2.0”, Blood Coag. Fibrin. 9, 741–748.
- Kalicinski, P., Kaminski, A., Drewniak, T., et al., (1999) “Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII”, Transplant. Proc. 31, 378–379.
- Young, G., Lloyd, S. and Nugent, D.J. (2000) “Recombinant factor VIIa in patients with liver failure undergoing surgery”, Blood 96(suppl. 1), 267a.
- Lachaux, A., LeGall, C., Chambon, M., et al., (1995) “Complications of percutaneous liver biopsy in infants and children”, Eur. J. Pediatr. 154, 621–623.
- McMahon, C., Pilkington, R., Shea, E.O., Kelleher, D. and Smith, O.P. (2000) “Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders”, Br. J. Haematol. 109, 354–359.
- Vohra, P., Haller, C., Emre, S., et al., (2000) “Neonatal hemochromatosis: importance of early recognition of liver failure”, J. Pediatr. 136, 537–541.
- Monroe, D.M., Hoffman, M., Oliver, J.A. and Roberts, H.R. (1998) “A possible mechanism of action of activated factor VII independent of tissue factor”, Blood Coag. Fibrin. 9(suppl. 1), S15–S20.
- Schulman, S., Bech Jensen, M., Varon, D., Keller, N., et al., (1996) “Feasibility of using recombinant factor VIIa in continuous infusion”, Thromb. Haemost. 75, 432–436.